Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary

J Oncol Pract. 2016 Apr;12(4):384-9. doi: 10.1200/JOP.2016.010868. Epub 2016 Mar 8.

Authors

Lyndsay N Harris¹, Nofisat Ismaila¹, Lisa M McShane¹, Daniel F Hayes¹

Affiliation

¹ Case Western Reserve University, Cleveland, OH; American Society of Clinical Oncology, Alexandria, VA; National Cancer Institute, Bethesda, MD; and University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

PMID: 26957642
DOI: 10.1200/JOP.2016.010868

No abstract available

Publication types

Practice Guideline

MeSH terms

Biomarkers
Breast Neoplasms / diagnosis*
Breast Neoplasms / therapy*
Clinical Decision-Making
Combined Modality Therapy
Female
Humans
Neoplasm Invasiveness
Neoplasm Staging

Substances

Biomarkers